Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
330
-
Total 13F shares, excl. options
-
69.7M
-
Shares change
-
-528K
-
Total reported value, excl. options
-
$6.87B
-
Value change
-
-$50.7M
-
Put/Call ratio
-
0.7
-
Number of buys
-
152
-
Number of sells
-
-128
-
Price
-
$98.67
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2017
359 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2017.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 330 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.7M shares
of 71.9M outstanding shares and own 96.86% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9.31M shares), Vanguard Group Inc (6.79M shares), BlackRock Inc. (6.23M shares), FRANKLIN RESOURCES INC (3.9M shares), Neuberger Berman Group LLC (3.41M shares), STATE STREET CORP (2.46M shares), Select Equity Group, L.P. (2.39M shares), ALLIANCEBERNSTEIN L.P. (2.04M shares), JPMORGAN CHASE & CO (1.85M shares), and BAMCO INC /NY/ (1.8M shares).
This table shows the top 330 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.